Literature DB >> 32428810

Do pets protect their owners in the COVID-19 era?

Jan Jurgiel1, Krzysztof J Filipiak2, Łukasz Szarpak3, Miłosz Jaguszewski4, Jacek Smereka5, Tomasz Dzieciątkowski6.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32428810      PMCID: PMC7215164          DOI: 10.1016/j.mehy.2020.109831

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


× No keyword cloud information.

Introduction

The outbreak of COVID-19 – the global spread of the disease caused by SARS-CoV2 – took place at the end of 2019 in Wuhan, China [1]. After the infection of more than 120.000 people and the death of almost 5.000, the World Health Organization announced it as a global controllable pandemic [2]. In April of 2020, the number of cases exceeded 2 million and the infection was spread over more than 180 countries [3], [4]. Human coronaviruses (HCoVs) were on the origin of not only the current pandemic, but also of the SARS and MERS epidemics, which infected and took the lives of thousands of people [5], [6]. Virologic and genetical studies confirmed that bats have been transmission hosts for both of the viruses, which were further spread by civets and dromedaries [7], [8], [9]. Recent studies suggest that specific types of animals can be the source of different coronaviruses: bats for alpha- and beta-CoVs, avian for gamma- and delta-CoVs, and rodents for the ancestor of the beta-CoVs lineage A [10], [11], [12]. The infection is not exclusive to wild animals and there are many known strains that affect livestock and pets [13]. Symptoms caused by coronaviruses depend on the type of strain; they may include gastrointestinal ailments (diarrhoea, vomiting, anorexia), respiratory ailments (dyspnoea, coughing, wheezing) and others. The animal origin of the novel coronavirus led to a discussion about the possible transmission of the disease by contact with pets. A common fear that raised even more after the confirmation of the SARS-CoV2 in a tiger in the Bronx zoological garden [14]. The World Health Organization faced those concerns stating the lack of evidence on the spreading of the novel coronavirus from pet animals to people [15]. The empirical observations show that the presence of pets may have a positive impact on the course of COVID-19. Anecdotal evidence try to persuade that veterinary doctors are rarely affected with COVID-19. Doctor Sabina Olex-Condor, a Spanish physician in Madrid, suggested in an interview that the mild course is more frequent in patients owning pets (available at: www.vetnolimits.com; www.psy.pl; www.plus.gloswielkopolski.pl). The correlation between pet-ownership and the presence of a mild course of COVID-19 has not been found yet. In our study, we conducted a review of the literature, trying to establish a possible explanation to this observation. We suggest that the re-emerging contact with animal coronaviruses may lead to the stimulation of the immunological system, thus creating an effective response to SARS-CoV-2 infection.

The occurrence of the animal coronavirus in pets

The possible positive effect of pet-ownership can be considered if the presence of the animal coronaviruses is high across the pet population. Therefore, we studied the papers presenting the occurrence of the animal coronaviruses. In our analysis, we focus on dogs, due to two reasons: 1) they are the most common species taken as home pets [16], 2) canine coronaviruses can be transmitted easily to humans via droplets. Feline coronaviruses are also detected in cats, but their symptoms are mainly related to the gastrointestinal tract or are causative agent of uncommon and usually fatal, aberrant immune response to viral infection, but transmission animal-to-human is highly limited [17]. Table 1 shows the detection rate in dogs. According to studies, the detection of canine respiratory coronavirus (CrCoV) is settled from 7.5% to 54.7%. Studies with the most prominent sample (Priestnal et al. 2006 and More et al. 2020) showed detection: 54.7% for North America, 36.0% for the United Kingdom, and 53.0% for New Zealand.
Table 1

Summary of studies detecting coronaviruses rate in dogs.

AuthorNumber of samples (n)Detection rateMethodRegion
Priestnal et al. (2006) [18]100082454.7%36.0%Serology testingNorth AmericaUK
More et al. (2020) [19]101553.0%Serology testingNew Zealand
Priestnal et al. (2007) [20]49023.3%Serology testingItaly
An et al. (2010) [21]48312.8%Serology testingKorea
Hielb et al. (2019) [22]2647.5%Serology testingAustria
Knesl et al. (2009) [23]25129.0%Serology testingNew Zealand
Mitchell et al. (2017) [24]24747.0%7.7%Serology testingmolecular testingEurope
Decarao et al. (2007) [25]21532.0%Serology testingItaly
Schulz et al. (2014) [26]1519.8%Molecular testingGermany
Erles et al. (2003) [27]11937.0%Molecular testingUK
Erles et Brownlie [28](2005)11338.9%Serology testingUK
Sowman et al. (2018) [29]9350.5%Serology testingNew Zealand
Wille et al. (2020) [30]8814.7%Molecular testingSweden
Summary of studies detecting coronaviruses rate in dogs. Data show that the occurrence of CrCoV is high in dogs, which might suggest that humans who possess a pet can have more frequent contact with different types of canine coronaviruses. Since the infected pets may not have symptoms, the contact of owners with pathogens can be unnoticed [31].

Cross-reactivity and immune system mobilization

The human immunological system fights different viral infections by three pathways: 1) interferon-mediated, 2) cytotoxic cells-mediated, and 3) antibody-mediated [32]. On the first, interferons provide an effective immunological reaction by the activation of NK-cells and macrophages, repression of viral proteins production, and regulation of antigen presentation to T-cells. On the second path, cytotoxic cells can directly kill the host cells infected by the virus using specific receptors and enzymes, thus stopping further infection [33]. The antibody-mediated ceasing of infection can be executed through different mechanisms: agglutination, phagocytosis or complement system degradation, but all of these are stimulated by the antibody opsonisation [32]. The effectiveness of this process is related to the specificity of the antibody – the capability of the antibody to discriminate between similar and dissimilar antigens. However, due to cross-reactivity, antibodies can respond to other antigen due to the resemblance of its structures [34]. Response to a similar antigen can lead to effective immunological protection as it was executed against the primary target. The cross-reactivity is related to the degree of the resemblance of the primary antigen to the other, for example: neutralizing antibodies against “old” SARS-CoV have moderate binding force to novel coronavirus SARS-CoV-2. The coronaviruses genome encodes for four structural and sixteen non-structural proteins, approximately [35], [36]. The spike proteins (S-protein) are the structural proteins that recognize and attach to ACE2 located on the cell membrane of the airways epithelia and lung parenchyma. In their study, Tilocca and colleagues sequenced the SARS-CoV-2 aminoacidic sequence and compared it to the sequences derived from the other animal coronaviruses [37]. The analysis showed that the resemblance of the whole sequence between SARS-CoV-2 and Canine Respiratory Coronavirus (CrCoV) is 36.39% (comparing the protein GI QHR63290 to QAY30030). However, further investigation of the epitope sequence shows the high homology: 57.14%, 80.00%, 83.33%, and 100.00% in CrCoV epitopes: 789–799, 754–764, 424–437, and 1139–1152, respectively. Based on the data, we suggest that recurrent contact with animal coronaviruses may lead to immunization. This effect was confirmed by the experimental studies. The investigation conducted by Lu and colleagues, showed that the nucleocapsid protein derived from CrCoV and expressed in E. coli displayed antigenic cross-reactivity with antisera against human coronaviruses [38]. Furthermore, Zhao and colleagues propose one more explanation to the protective effect of the contact with zoonotic coronaviruses [39]. Cross-reactivity with T-cells can induce the immunological response. CD4+ memory T-cells on the epithelium of the airways can effectively produce interferon-gamma, which leads to activation of other cells and effective reaction. Thus, patients owning pets could have a mild course of the SARS-CoV-2 infection, which was observed in Spain. The recurrent contact with pathogens may work as immune-mobilization against SARS-CoV-2 in many different paths.

Conclusions

Canine respiratory coronaviruses occur often among dogs. Ownership of a pet can lead to the contact with dogscoronaviruses. Re-occurring contact with dogscoronaviruses might stimulate the human immunological system, and provide an effective response to SARS-COV-2. There is a need for further investigation on the correlation between pet ownership and the course of COVID-19. Such data, even obtain retrospectively, are worth to analyse.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  31 in total

1.  What the cruise-ship outbreaks reveal about COVID-19.

Authors:  Smriti Mallapaty
Journal:  Nature       Date:  2020-04       Impact factor: 49.962

2.  Genetic and antigenic characterization of recombinant nucleocapsid proteins derived from canine coronavirus and canine respiratory coronavirus in China.

Authors:  Shuai Lu; Yingzhu Chen; Kun Qin; Jianfang Zhou; Yongliang Lou; Wenjie Tan
Journal:  Sci China Life Sci       Date:  2016-04-15       Impact factor: 6.038

3.  A survey of canine respiratory pathogens in New Zealand dogs.

Authors:  H R Sowman; N J Cave; M Dunowska
Journal:  N Z Vet J       Date:  2018-07-18       Impact factor: 1.628

4.  Serological prevalence of canine respiratory coronavirus in southern Italy and epidemiological relationship with canine enteric coronavirus.

Authors:  Simon Lawrence Priestnall; Annamaria Pratelli; Joe Brownlie; Kerstin Erles
Journal:  J Vet Diagn Invest       Date:  2007-03       Impact factor: 1.279

5.  Canine coronavirus highly pathogenic for dogs.

Authors:  Canio Buonavoglia; Nicola Decaro; Vito Martella; Gabriella Elia; Marco Campolo; Costantina Desario; Massimo Castagnaro; Maria Tempesta
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883

6.  Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa.

Authors:  Ndapewa Laudika Ithete; Samantha Stoffberg; Victor Max Corman; Veronika M Cottontail; Leigh Rosanne Richards; M Corrie Schoeman; Christian Drosten; Jan Felix Drexler; Wolfgang Preiser
Journal:  Emerg Infect Dis       Date:  2013-10       Impact factor: 6.883

Review 7.  Epidemiological and genetic analysis of severe acute respiratory syndrome.

Authors:  Christl A Donnelly; Matthew C Fisher; Christophe Fraser; Azra C Ghani; Steven Riley; Neil M Ferguson; Roy M Anderson
Journal:  Lancet Infect Dis       Date:  2004-11       Impact factor: 25.071

8.  Detection of respiratory viruses and Bordetella bronchiseptica in dogs with acute respiratory tract infections.

Authors:  B S Schulz; S Kurz; K Weber; H-J Balzer; K Hartmann
Journal:  Vet J       Date:  2014-05-06       Impact factor: 2.688

9.  Molecular diversity of coronaviruses in bats.

Authors:  Patrick C Y Woo; Susanna K P Lau; Kenneth S M Li; Rosana W S Poon; Beatrice H L Wong; Hoi-wah Tsoi; Bethanie C K Yip; Yi Huang; Kwok-hung Chan; Kwok-yung Yuen
Journal:  Virology       Date:  2006-05-02       Impact factor: 3.616

10.  A serological survey of canine respiratory coronavirus in New Zealand.

Authors:  G D More; M Dunowska; E Acke; N J Cave
Journal:  N Z Vet J       Date:  2019-10-06       Impact factor: 1.628

View more
  4 in total

1.  Severe acute respiratory syndrome coronavirus 2 in cats: a systematic review.

Authors:  Ana Izabel Passarella Teixeira; Ligia Cantarino
Journal:  Rev Bras Med Vet       Date:  2021-06-01

2.  Do pets protect their owners in the COVID-19 era?

Authors: 
Journal:  Adv Small Anim Med Surg       Date:  2020-11-04

3.  The Differences in the Level of Anti-SARS-CoV-2 Antibodies after mRNA Vaccine between Convalescent and Non-Previously Infected People Disappear after the Second Dose-Study in Healthcare Workers Group in Poland.

Authors:  Joanna Kwiecińska-Piróg; Jana Przekwas; Zuzanna Kraszewska; Alicja Sękowska; Sylwia Brodzka; Natalia Wiktorczyk-Kapischke; Katarzyna Grudlewska-Buda; Ewa Wałecka-Zacharska; Maciej Zacharski; Aneta Mańkowska-Cyl; Eugenia Gospodarek-Komkowska; Krzysztof Skowron
Journal:  Vaccines (Basel)       Date:  2021-11-27

Review 4.  Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review.

Authors:  Sina Salajegheh Tazerji; Phelipe Magalhães Duarte; Parastoo Rahimi; Fatemeh Shahabinejad; Santosh Dhakal; Yashpal Singh Malik; Awad A Shehata; Juan Lama; Jörn Klein; Muhammad Safdar; Md Tanvir Rahman; Krzysztof J Filipiak; Alfonso J Rodríguez-Morales; Md Abdus Sobur; Farrokhreza Kabir; Bita Vazir; Leonard Mboera; Marco Caporale; Md Saiful Islam; John H Amuasi; Rasha Gharieb; Paola Roncada; Sahar Musaad; Bruno Tilocca; Mohammad Kazem Koohi; Ali Taghipour; Ahmet Sait; Kannan Subbaram; Alireza Jahandideh; Pejman Mortazavi; Mohammad Amin Abedini; David A Hokey; Unarose Hogan; Mohamed N F Shaheen; Ahmed Elaswad; Mahmoud M Elhaig; Mohamed Fawzy
Journal:  J Transl Med       Date:  2020-09-21       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.